Profil
Federico Zuckermann is associated with Aptimmune Biologics, Inc. as the Chief Scientific Officer since 2010.
He is the founder of Aptimmune Biologics, Inc. which was founded in 2010.
Postes actifs de Federico Zuckermann
| Sociétés | Poste | Début |
|---|---|---|
Aptimmune Biologics, Inc.
 Aptimmune Biologics, Inc. Medical/Nursing ServicesHealth Services Aptimmune Biologics, Inc. develops and markets a portfolio of revolutionary mucosal vaccines. It focuses on swine vaccines and the prevention of porcine reproductive and respiratory syndrome virus and influenza. The company was founded by Federico Zuckermann in 2010 and is headquartered in Champaign, IL. | Fondateur | 01/01/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aptimmune Biologics, Inc.
Aptimmune Biologics, Inc. Medical/Nursing ServicesHealth Services Aptimmune Biologics, Inc. develops and markets a portfolio of revolutionary mucosal vaccines. It focuses on swine vaccines and the prevention of porcine reproductive and respiratory syndrome virus and influenza. The company was founded by Federico Zuckermann in 2010 and is headquartered in Champaign, IL. | Health Services |
